BIOMERICA INC (BMRA) Shareholder Equity
- 2026-05-31: Common Stock, Value, IssuedUSD $255.00K; Additional Paid in CapitalUSD $59.43M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-108.00K; Retained Earnings (Accumulated Deficit)USD $-56.94M.
- 2026-02-28: Common Stock, Value, IssuedUSD $242.00K; Additional Paid in CapitalUSD $58.98M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-103.00K; Retained Earnings (Accumulated Deficit)USD $-55.80M.
- 2025-11-30: Common Stock, Value, IssuedUSD $236.00K; Additional Paid in CapitalUSD $58.79M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-103.00K; Retained Earnings (Accumulated Deficit)USD $-54.49M.
- 2025-08-31: Common Stock, Value, IssuedUSD $225.00K; Additional Paid in CapitalUSD $58.20M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-102.00K; Retained Earnings (Accumulated Deficit)USD $-53.17M.
BIOMERICA INC Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $255.00K | $59.43M | $-108.00K | $-56.94M | $2.63M | (m) | (m) | (m) | (m) |
| 2026-02-28 | $242.00K | $58.98M | $-103.00K | $-55.80M | $3.32M | (m) | (m) | (m) | (m) |
| 2025-11-30 | $236.00K | $58.79M | $-103.00K | $-54.49M | $4.43M | 3 month · $118.00K | (m) | (m) | (m) |
| 2025-08-31 | $225.00K | $58.20M | $-102.00K | $-53.17M | $5.16M | (m) | (m) | (m) | (m) |
| 2025-05-31 | $203.00K | $57.17M | $-105.00K | $-53.17M | $4.11M | 12 month · $460.00K | (m) | (m) | (m) |
| 2025-05-13 | $203.00K | $57.17M | $-105.00K | $-53.17M | $4.11M | (m) | (m) | (m) | (m) |
| 2025-02-28 | $1.63M | $55.64M | $-113.00K | $-51.62M | $5.53M | 3 month · $120.00K | (m) | (m) | (m) |
| 2024-11-30 | $1.47M | $54.22M | $-112.00K | $-50.46M | $5.11M | 3 month · $155.00K | (m) | (m) | (m) |
| 2024-08-31 | $1.35M | $53.62M | $-108.00K | $-49.51M | $5.35M | 3 month · $77.00K | (m) | (m) | (m) |
| 2024-05-31 | $168.00K | $54.72M | $-102.00K | $-48.20M | $6.59M | 12 month · $837.00K | (m) | (m) | (m) |
| 2024-02-29 | $1.35M | $53.34M | $-102.00K | $-46.77M | $7.81M | 3 month · $341.00K | (m) | (m) | (m) |
| 2023-11-30 | $1.35M | $53.00M | $-104.00K | $-44.86M | $9.38M | 3 month · $122.00K | (m) | (m) | (m) |
| 2023-08-31 | $1.35M | $52.88M | $-104.00K | $-43.35M | $10.77M | 3 month · $170.00K | (m) | (m) | (m) |
| 2023-05-31 | $1.35M | $52.70M | $-110.00K | $-42.22M | $11.72M | 12 month · $1.19M | (m) | (m) | (m) |
| 2023-02-28 | $1.08M | $45.44M | $-110.91K | $-40.43M | $5.99M | 3 month · $384.00K | (m) | (m) | (m) |
| 2022-11-30 | $1.08M | $45.04M | $-95.41K | $-38.78M | $7.24M | 3 month · $318.00K | (m) | (m) | (m) |
| 2022-08-31 | $1.07M | $44.48M | $-86.46K | $-37.15M | $8.32M | 3 month · $304.00K | (m) | (m) | (m) |
| 2022-05-31 | $1.03M | $42.45M | $-74.00K | $-35.08M | $8.32M | 12 month · $1.26M | (m) | 12 month · $1.26M | (m) |
| 2022-02-28 | $1.03M | $42.11M | $-60.86K | $-33.32M | $9.76M | (m) | (m) | (m) | (m) |
| 2021-11-30 | $1.02M | $41.16M | $-58.32K | $-33.21M | $8.90M | (m) | (m) | 6 month · $634.02K | (m) |
| 2021-08-31 | $1.00M | $39.94M | $-53.57K | $-32.09M | $8.80M | (m) | (m) | 3 month · $319.62K | (m) |
| 2021-05-31 | $984.57K | $38.84M | $-47.96K | $-30.55M | $9.23M | (m) | (m) | 12 month · $1.35M | (m) |
| 2021-02-28 | $984.17K | $36.56M | $-48.53K | $-26.90M | $10.60M | (m) | (m) | 9 month · $261.18K | (m) |
| 2020-11-30 | $941.61K | $35.28M | $-43.09K | $-25.06M | $11.15M | (m) | $25.71K | 6 month · $500.14K | (m) |
| 2020-08-31 | $940.21K | $35.23M | $-41.56K | $-23.58M | $12.58M | (m) | $25.71K | 3 month · $246.79K | (m) |
| 2020-05-31 | $939.21K | $36.39M | $-39.84K | $-23.10M | $14.21M | (m) | $25.71K | 12 month · $538.59K | (m) |
| 2020-02-29 | $824.83K | $26.45M | $-40.69K | $-21.44M | $4.68M | (m) | $45.71K | 9 month · $192.92K | (m) |
| 2019-11-30 | $788.09K | $23.22M | $-41.62K | $-20.58M | $3.38M | (m) | (m) | 6 month · $34.98K | (m) |
| 2019-08-31 | $781.50K | $22.98M | $-39.97K | $-20.09M | $3.62M | (m) | (m) | 3 month · $5.85K | (m) |
| 2019-05-31 | $774.17K | $22.83M | $-36.53K | $-19.59M | $3.98M | (m) | (m) | 12 month · $151.22K | (m) |
| 2019-02-28 | $746.69K | $22.05M | $-33.52K | $-18.80M | $3.95M | (m) | (m) | 9 month · $146.51K | (m) |
| 2018-11-30 | $743.14K | $21.82M | $-31.94K | $-18.12M | $4.41M | (m) | (m) | (m) | (m) |
| 2018-08-31 | $716.30K | $21.03M | $-27.46K | $-17.65M | $4.08M | (m) | (m) | (m) | (m) |
| 2018-05-31 | $711.04K | $20.84M | $-26.14K | $-17.19M | $4.33M | (m) | (m) | 12 month · $18.47K | 12 month · $-9.06K |
| 2018-02-28 | $689.75K | $19.89M | $-22.14K | $-16.53M | $4.00M | (m) | (m) | (m) | (m) |
| 2017-11-30 | $682.36K | $19.57M | $-21.00K | $-16.20M | $4.03M | (m) | (m) | (m) | (m) |
| 2017-08-31 | $680.97K | $19.56M | $-16.66K | $-15.93M | $4.29M | (m) | (m) | (m) | (m) |
| 2017-05-31 | $680.89K | $19.55M | $-15.83K | $-15.73M | $4.49M | (m) | (m) | 12 month · $21.73K | (m) |
| 2017-02-28 | $680.41K | $19.54M | $-14.59K | $-15.38M | $4.82M | (m) | (m) | (m) | (m) |
| 2016-11-30 | $664.04K | $19.45M | $-14.35K | $-15.08M | $5.02M | (m) | (m) | (m) | (m) |
| 2016-08-31 | $653.57K | $19.40M | $-13.56K | $-14.87M | $5.17M | (m) | (m) | (m) | (m) |
| 2016-05-31 | $653.57K | $19.40M | $-13.59K | $-14.82M | $5.22M | (m) | (m) | 12 month · $15.15K | (m) |
| 2016-02-29 | $612.75K | $18.38M | $-13.70K | $-13.59M | $5.39M | (m) | (m) | (m) | (m) |
| 2015-11-30 | $607.22K | $18.34M | $-13.63K | $-13.46M | $5.47M | (m) | (m) | (m) | (m) |
| 2015-08-31 | $606.76K | $18.33M | $-12.61K | $-13.39M | $5.54M | (m) | (m) | (m) | (m) |
| 2015-05-31 | $605.34K | $18.33M | $-12.26K | $-13.32M | $5.60M | (m) | (m) | 12 month · $10.02K | (m) |
| 2015-02-28 | $604.38K | $18.32M | $-12.14K | $-13.56M | $5.35M | (m) | (m) | (m) | (m) |
| 2014-11-30 | $604.22K | $18.31M | $-11.83K | $-13.45M | $5.46M | (m) | (m) | (m) | (m) |
| 2014-08-31 | $604.16K | $18.31M | $-11.08K | $-13.21M | $5.70M | (m) | (m) | (m) | (m) |
| 2014-05-31 | $603.50K | $18.31M | $-10.15K | $-12.99M | $5.91M | (m) | (m) | 12 month · $11.00K | (m) |
| 2014-02-28 | $601.10K | $18.29M | $-10.12K | $-13.16M | $5.73M | (m) | (m) | (m) | (m) |
| 2013-11-30 | $582.34K | $18.04M | $-9.02K | $-13.18M | $5.43M | (m) | (m) | (m) | (m) |
| 2013-08-31 | $582.14K | $18.04M | $-9.10K | $-12.94M | $5.67M | (m) | (m) | (m) | (m) |
| 2013-05-31 | $581.98K | $18.03M | $-9.01K | $-12.77M | $5.83M | (m) | (m) | 12 month · $20.86K | (m) |
| 2013-02-28 | $564.02K | $17.79M | $-8.74K | $-12.82M | $5.53M | (m) | (m) | (m) | (m) |
| 2012-11-30 | $557.79K | $17.74M | $-6.58K | $-12.78M | $5.51M | (m) | (m) | (m) | (m) |
| 2012-08-31 | $556.19K | $17.74M | $-6.11K | $-13.02M | $5.27M | (m) | (m) | (m) | (m) |
| 2012-05-31 | $556.19K | $17.74M | $-6.03K | $-13.31M | $4.98M | (m) | (m) | 12 month · $53.62K | (m) |
| 2012-02-29 | $553.47K | $17.70M | $-5.99K | $-13.36M | $4.88M | (m) | $0.00 | (m) | (m) |
| 2011-11-30 | $549.47K | $17.65M | $-6.08K | $-13.54M | $4.65M | (m) | (m) | (m) | (m) |
| 2011-08-31 | $549.47K | $17.64M | $-4.90K | $-13.74M | $4.45M | (m) | (m) | (m) | (m) |
| 2011-05-31 | $549.47K | $17.64M | $-4.46K | $-13.86M | $4.33M | (m) | $0.00 | (m) | (m) |
| 2010-05-31 | (m) | (m) | (m) | (m) | $4.06M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |